Novel therapies

Can novel therapies, including stem-cell, gene, pharmacological and neuroprotective therapies, improve the health and wellbeing of people living with DCM and slow down disease progression? 

Podcast Episode 7: Novel therapies

Novel therapies for DCM—the topic of Episode 7 of the AO Spine RECODE-DCM Podcast series. What are the limitations and potential advances of current therapies, how can novel experimental treatment paradigms deliver progress, how could strategies for neurorehabilitation advance the field? Ben Davies and Michelle Starkey put the questions to Ricardo Rodrigues-Pinto, Annie Wandycz, Mark Kotter, and Julio Furlan.

Current evidence and reason for uncertainties

No systematic reviews, scoping reviews or guidelines identified.

Source of uncertainty

  • Spinal surgeons

    59

  • Other healthcare professionals

    15

  • People with DCM and their supporters

    29

Podcast Episode 7: Novel therapies

Novel therapies for DCM—the topic of Episode 7 of the AO Spine RECODE-DCM Podcast series. What are the limitations and potential advances of current therapies, how can novel experimental treatment paradigms deliver progress, how could strategies for neurorehabilitation advance the field? Ben Davies and Michelle Starkey put the questions to Ricardo Rodrigues-Pinto, Annie Wandycz, Mark Kotter, and Julio Furlan.